Safaa Ibrahim Tayel

Dr. Safaa Ibrahim Tayel

Menoufia University
orcid

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 July 2022 in International Journal of Biological Sciences
Verified
Journal Article
Open access
STSafaa Ibrahim Tayel
Safaa Ibrahim Tayel
EEEman A. El-Masry
Eman A. El-Masry
GAGehan A. Abdelaal
Gehan A. Abdelaal
SSSomaia Shehab-Eldeen
Somaia Shehab-Eldeen
AEAbdallah Essa
Abdallah Essa
NMNashwa M. Muharram
Nashwa M. Muharram
Background: In 2019, the coronavirus pandemic emerged, resulting in the highest mortality and morbidity rate globally. It has a prevailing transmission rate and continues to be a global burden. There is a paucity of data regarding the role of long non-coding RNAs (lncRNAs) in COVID-19. Therefore, the current study aimed to investigate lncRNAs, particularly NEAT1 and TUG1, and their association with IL-6, CCL2, and TNF-α in COVID-19 patients with moderate and severe disease.

1 June 2018 in Steroids
Verified
Journal Article
Closed access
STSafaa Ibrahim Tayel
Safaa Ibrahim Tayel
SSShimaa E. Soliman
Shimaa E. Soliman
HEHanan M. Elsayed
Hanan M. Elsayed

28 April 2020 in Current Molecular Medicine
Verified
Journal Article
Closed access
PDF file
STSafaa Ibrahim Tayel
Safaa Ibrahim Tayel
ASAmany A. Saleh
Amany A. Saleh
SESally M. El-Hefnawy
Sally M. El-Hefnawy
Khaled Mohamed Amin ElzorkanyKhaled Mohamed Amin Elzorkany
Khaled Mohamed Amin Elzorkany
GEGhada Elgarawany
Ghada Elgarawany
RNRasha I. Noreldin
Rasha I. Noreldin
Background and Aim: Diabetic nephropathy (DN) is a major determinant of end-stage renal disease (ESRD). Altered microRNA levels lead to serious chronic diseases, such as diabetes. We aimed to measure the expression levels of two microRNAs, microRNA126 and 192 in DN and investigate their connection with albuminuria levels. Methods: This study included 229 subjects (134 DN patients and 95 controls). Serum lipid profiles, glucose levels, glycated haemoglobin (HbA1c) levels, and renal functions were assayed. The microRNA126 and microRNA192 expression levels were determined by real-time PCR. Results: Patients with DN had higher weights, BMI values, glucose levels (p<0.001), HbA1c levels (p<0.001), urinary albumin-creatinine ratio (ACR) values (p<0.001), urea levels (P=0.002), and creatinine levels (P=0.004) and lower expression levels of both microRNA192 (p<0.001) and microRNA126 (p<0.001) than controls. MicroRNA126 expression was positively correlated with age, estimated glomerular filtration rate (eGFR) and microRNA192 expression but negatively correlated with blood sugar, HbA1c, urea, creatinine and ACR. MicroRNA192 had higher sensitivity (91%), specificity (94%), and area under the curve (AUC) (0.967) values than microRNA126 (sensitivity, 90%; specificity, 68%; AUC, 0.897) and thus can precisely diagnose DN. Conclusion: Both MicroRNA126 and microRNA192 expression were obviously associated with DN and might determine the progression of the disease owing to prominent relation with macroalbuminuria.

18 January 2017 in Respiratory Research
Verified
Journal Article
Open access
PDF file
STSafaa Ibrahim Tayel
Safaa Ibrahim Tayel
SESally M. El-Hefnway
Sally M. El-Hefnway
EGEman M. Abd El Gayed
Eman M. Abd El Gayed
GAGehan A. Abdelaal
Gehan A. Abdelaal
Bronchial asthma is a chronic inflammatory and remodeling disorder of the airways, in which many cells, cellular elements, and cytokines play important roles. Stem cell factor (SCF) may contribute to the inflammatory changes occurring in asthma. We aimed to show the expression of SCF gene in patients with asthma as a means of diagnosis and its association with severity and atopic state in these patients. This study was carried out on 80 subjects, 50 asthmatic patients and 30 age and gender matched healthy control persons. They were subjected to full history taking, general and local chest examination, spirometric measurements (pre and post broncodilators) using a spirometer, serum IgE, and real time PCR for assessment of SCF mRNA expression. This study showed significant difference between the studied groups regarding pulmonary function tests (P < 0.001). Asthmatic patients had significant higher SCF expression compared to control (P < 0.001), also atopic patients vs non atopic (P = 0.03) and severe asthmatic patients vs mild ones (P < 0.001). SCF expression at cut off point (0.528) is sufficient to discriminate asthmatic patients from control while at cut off point (1.84) for discrimination of atopic patients from non-atopic patients and at cut off point (1.395) for discrimination of severe asthmatic patients from mild ones. A significant negative correlation between SCF expression and inhaled steroid while significant positive correlation with serum IgE was found. Measuring SCF mRNA expression can be used as an efficient marker for evaluation of atopy and detection of severity of bronchial asthma.

1 June 2018 in Archives of Biochemistry and Biophysics
Verified
Journal Article
Closed access
STSafaa Ibrahim Tayel
Safaa Ibrahim Tayel
EFEman A.M. Fouda
Eman A.M. Fouda
SGSuzy F. Gohar
Suzy F. Gohar
EEElsayed I. Elshayeb
Elsayed I. Elshayeb
EEEman H. El-Sayed
Eman H. El-Sayed
SESalah M. El-Kousy
Salah M. El-Kousy

25 March 2018 in Journal of Cellular Biochemistry
Verified
Journal Article
Closed access
PDF file
STSafaa Ibrahim Tayel
Safaa Ibrahim Tayel
EFEman A. M. Fouda
Eman A. M. Fouda
EEElsayed I. Elshayeb
Elsayed I. Elshayeb
AEAsmaa R. A. Eldakamawy
Asmaa R. A. Eldakamawy
SESalah M. El‐Kousy
Salah M. El‐Kousy